HBI Deals+Insights / Healthcare Reform
Mediclinic-owned Swiss hospital group Hirslanden looks set to close a 28-bed hospital unless "alternative proposals" can be found, blaming tariff changes and moves by the local Canton. It is less than 1% of Hirslanden's sales but is the first casualty of the tariff reforms amongst the hospital market's big players. We talk to the CEOs of both Mediclinic International and Hirslanden about the closure and the Swiss market generally.